PAT4CGT Project Reaches Key Milestone as it Seeks to Scale CGT Manufacturing

We have successfully completed testing of our second-generation prototype, enabling the development of a third iteration of the device. The upcoming version is designed to expand the platform’s utility, with the capability to assess NK cells, CAR T cells, and viral vectors, supporting broader applications across the cell and gene therapy landscape.